{"date":"2026-03-11","count":109,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-4736-2026-03-11-2044-1howjn","company_id":"4736","company":"泰博","market":"上市","industry":"生技醫療","date":"2026-03-11","time":"20:44:27","subject":"公告本公司董事會決議召開115年股東常會","clause":"第17款","fact_date":"2026-03-11","cite_as":"公開資訊觀測站重大訊息：泰博（4736），2026-03-11 20:44，「公告本公司董事會決議召開115年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6696-2026-03-11-2016-1sp9mjr","company_id":"6696","company":"仁新*","market":"興櫃","industry":"生技醫療","date":"2026-03-11","time":"20:16:38","subject":"代重要子公司Belite Bio, Inc公告董事會決議通過現金增資子公司Belite Bio Holdings Corp.","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仁新*（6696），2026-03-11 20:16，「代重要子公司Belite Bio, Inc公告董事會決議通過現金增資子公司Belite Bio Holdings Cor」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4736-2026-03-11-2016-1h3ceio","company_id":"4736","company":"泰博","market":"上市","industry":"生技醫療","date":"2026-03-11","time":"20:16:13","subject":"公告本公司董事會決議買回庫藏股","clause":"第35款","fact_date":"2026-03-11","cite_as":"公開資訊觀測站重大訊息：泰博（4736），2026-03-11 20:16，「公告本公司董事會決議買回庫藏股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2026-03-11-2013-v47tfz","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2026-03-11","time":"20:13:59","subject":"公告本公司董事會通過115年股東常會召開相關事宜(新增議案)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2026-03-11 20:13，「公告本公司董事會通過115年股東常會召開相關事宜(新增議案)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4736-2026-03-11-2009-sfe0ar","company_id":"4736","company":"泰博","market":"上市","industry":"生技醫療","date":"2026-03-11","time":"20:09:24","subject":"本公司董事會決議資本公積轉增資發行新股","clause":"第11款","fact_date":"2026-03-11","cite_as":"公開資訊觀測站重大訊息：泰博（4736），2026-03-11 20:09，「本公司董事會決議資本公積轉增資發行新股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4736-2026-03-11-2006-13bqai2","company_id":"4736","company":"泰博","market":"上市","industry":"生技醫療","date":"2026-03-11","time":"20:06:27","subject":"本公司董事會決議股利分派","clause":"第14款","fact_date":"2026-03-11","cite_as":"公開資訊觀測站重大訊息：泰博（4736），2026-03-11 20:06，「本公司董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4736-2026-03-11-1959-1yhhv2w","company_id":"4736","company":"泰博","market":"上市","industry":"生技醫療","date":"2026-03-11","time":"19:59:40","subject":"本公司114年度合併財務報告業經董事會決議通過","clause":"第31款","fact_date":"2026-03-11","cite_as":"公開資訊觀測站重大訊息：泰博（4736），2026-03-11 19:59，「本公司114年度合併財務報告業經董事會決議通過」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8436-2026-03-11-1935-1063vlj","company_id":"8436","company":"大江","market":"上櫃","industry":"生技醫療","date":"2026-03-11","time":"19:35:48","subject":"公告本公司董事會決議召開2026年股東常會事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：大江（8436），2026-03-11 19:35，「公告本公司董事會決議召開2026年股東常會事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8436-2026-03-11-1930-119ooin","company_id":"8436","company":"大江","market":"上櫃","industry":"生技醫療","date":"2026-03-11","time":"19:30:40","subject":"公告本公司2025年度合併財務報告業經董事會決議通過","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：大江（8436），2026-03-11 19:30，「公告本公司2025年度合併財務報告業經董事會決議通過」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1783-2026-03-11-1924-c07evd","company_id":"1783","company":"和康生","market":"上市","industry":"生技醫療","date":"2026-03-11","time":"19:24:19","subject":"公告更正資金貸與資訊揭露明細表","clause":"第51款","fact_date":"2026-03-11","cite_as":"公開資訊觀測站重大訊息：和康生（1783），2026-03-11 19:24，「公告更正資金貸與資訊揭露明細表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1783-2026-03-11-1920-1063vlj","company_id":"1783","company":"和康生","market":"上市","industry":"生技醫療","date":"2026-03-11","time":"19:20:04","subject":"公告本公司董事會決議召開2026年股東常會事宜","clause":"第17款","fact_date":"2026-03-11","cite_as":"公開資訊觀測站重大訊息：和康生（1783），2026-03-11 19:20，「公告本公司董事會決議召開2026年股東常會事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1783-2026-03-11-1917-119ooin","company_id":"1783","company":"和康生","market":"上市","industry":"生技醫療","date":"2026-03-11","time":"19:17:03","subject":"公告本公司2025年度合併財務報告業經董事會決議通過","clause":"第31款","fact_date":"2026-03-11","cite_as":"公開資訊觀測站重大訊息：和康生（1783），2026-03-11 19:17，「公告本公司2025年度合併財務報告業經董事會決議通過」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2026-03-11-1911-1m4hlde","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2026-03-11","time":"19:11:46","subject":"本公司董事會決議辦理減資彌補虧損","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2026-03-11 19:11，「本公司董事會決議辦理減資彌補虧損」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2026-03-11-1904-nk7rn8","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2026-03-11","time":"19:04:19","subject":"代重要子公司霖揚生技製藥股份有限公司公告南科廠關閉事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2026-03-11 19:04，「代重要子公司霖揚生技製藥股份有限公司公告南科廠關閉事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2026-03-11-1903-1wnee9p","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2026-03-11","time":"19:03:25","subject":"公告本公司財務長暨財務主管異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2026-03-11 19:03，「公告本公司財務長暨財務主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2026-03-11-1902-1vhu1xi","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2026-03-11","time":"19:02:55","subject":"公告本公司發言人異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2026-03-11 19:02，「公告本公司發言人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2026-03-11-1902-1bnzcw8","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2026-03-11","time":"19:02:29","subject":"公告對霖揚生技之資金貸與轉現金增資案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2026-03-11 19:02，「公告對霖揚生技之資金貸與轉現金增資案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2026-03-11-1901-13bqai2","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2026-03-11","time":"19:01:54","subject":"本公司董事會決議股利分派","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2026-03-11 19:01，「本公司董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4127-2026-03-11-1901-1etdr8s","company_id":"4127","company":"天良","market":"上櫃","industry":"生技醫療","date":"2026-03-11","time":"19:01:17","subject":"公告本公司董事會決議召開115年股東常會日期及相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：天良（4127），2026-03-11 19:01，「公告本公司董事會決議召開115年股東常會日期及相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4198-2026-03-11-1856-1h6cdy4","company_id":"4198","company":"欣大健康","market":"上櫃","industry":"生技醫療","date":"2026-03-11","time":"18:56:05","subject":"公告本公司董事會通過委任公司治理主管","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：欣大健康（4198），2026-03-11 18:56，「公告本公司董事會通過委任公司治理主管」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2026-03-11-1855-8mvv4s","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2026-03-11","time":"18:55:45","subject":"本公司民國114年度合併財務報告業經董事會決議通過","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2026-03-11 18:55，「本公司民國114年度合併財務報告業經董事會決議通過」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4198-2026-03-11-1855-tq97v6","company_id":"4198","company":"欣大健康","market":"上櫃","industry":"生技醫療","date":"2026-03-11","time":"18:55:27","subject":"公告本公司董事會決議辦理私募有價證券相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：欣大健康（4198），2026-03-11 18:55，「公告本公司董事會決議辦理私募有價證券相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4198-2026-03-11-1854-p40py1","company_id":"4198","company":"欣大健康","market":"上櫃","industry":"生技醫療","date":"2026-03-11","time":"18:54:54","subject":"公告本公司114年股東常會通過之私募有價證券案於期限屆滿後不繼續辦理","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：欣大健康（4198），2026-03-11 18:54，「公告本公司114年股東常會通過之私募有價證券案於期限屆滿後不繼續辦理」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4198-2026-03-11-1847-bwopfv","company_id":"4198","company":"欣大健康","market":"上櫃","industry":"生技醫療","date":"2026-03-11","time":"18:47:39","subject":"公告本公司董事會決議不分派股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：欣大健康（4198），2026-03-11 18:47，「公告本公司董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1799-2026-03-11-1844-vhhqv0","company_id":"1799","company":"易威","market":"上櫃","industry":"生技醫療","date":"2026-03-11","time":"18:44:02","subject":"本公司因有重大訊息待公布，經櫃買中心同意自115年3月12日起暫停交易","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：易威（1799），2026-03-11 18:44，「本公司因有重大訊息待公布，經櫃買中心同意自115年3月12日起暫停交易」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4198-2026-03-11-1843-18y62m","company_id":"4198","company":"欣大健康","market":"上櫃","industry":"生技醫療","date":"2026-03-11","time":"18:43:54","subject":"依公開發行公司資金貸與及背書保證處理準則第二十二條第一項第二款公告及第三款公告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：欣大健康（4198），2026-03-11 18:43，「依公開發行公司資金貸與及背書保證處理準則第二十二條第一項第二款公告及第三款公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4198-2026-03-11-1842-1cbipwa","company_id":"4198","company":"欣大健康","market":"上櫃","industry":"生技醫療","date":"2026-03-11","time":"18:42:50","subject":"公告本公司董事會通過114年度合併財報務告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：欣大健康（4198），2026-03-11 18:42，「公告本公司董事會通過114年度合併財報務告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4198-2026-03-11-1842-11b1948","company_id":"4198","company":"欣大健康","market":"上櫃","industry":"生技醫療","date":"2026-03-11","time":"18:42:07","subject":"公告本公司董事會決議召開115年股東常會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：欣大健康（4198），2026-03-11 18:42，「公告本公司董事會決議召開115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6934-2026-03-11-1817-1i9qab4","company_id":"6934","company":"心誠鎂","market":"上市","industry":"生技醫療","date":"2026-03-11","time":"18:17:48","subject":"公告本公司民國114年度財務報告董事會預計召開日期為115年3月12日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：心誠鎂（6934），2026-03-11 18:17，「公告本公司民國114年度財務報告董事會預計召開日期為115年3月12日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4746-2026-03-11-1811-10jca0t","company_id":"4746","company":"台耀","market":"上市","industry":"生技醫療","date":"2026-03-11","time":"18:11:23","subject":"本公司受邀參加凱基證券舉辦之法人說明會","clause":"第12款","fact_date":"2026-03-13","cite_as":"公開資訊觀測站重大訊息：台耀（4746），2026-03-11 18:11，「本公司受邀參加凱基證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6730-2026-03-11-1809-fnmwr9","company_id":"6730","company":"常廣","market":"上櫃","industry":"生技醫療","date":"2026-03-11","time":"18:09:31","subject":"公告本公司董事會任命副總經理","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：常廣（6730），2026-03-11 18:09，「公告本公司董事會任命副總經理」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7814-2026-03-11-1805-1q0mimy","company_id":"7814","company":"海昌生技","market":"上櫃","industry":"生技醫療","date":"2026-03-11","time":"18:05:25","subject":"公告本公司董事會決議辦理初次上櫃掛牌前現金增資發行新股案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：海昌生技（7814），2026-03-11 18:05，「公告本公司董事會決議辦理初次上櫃掛牌前現金增資發行新股案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7814-2026-03-11-1803-11b1948","company_id":"7814","company":"海昌生技","market":"上櫃","industry":"生技醫療","date":"2026-03-11","time":"18:03:00","subject":"公告本公司董事會決議召開115年股東常會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：海昌生技（7814），2026-03-11 18:03，「公告本公司董事會決議召開115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3205-2026-03-11-1750-1rv6mzd","company_id":"3205","company":"佰研","market":"上櫃","industry":"生技醫療","date":"2026-03-11","time":"17:50:11","subject":"公告本公司向關係人取得不動產","clause":"第20款","fact_date":"2026-03-11","cite_as":"公開資訊觀測站重大訊息：佰研（3205），2026-03-11 17:50，「公告本公司向關係人取得不動產」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6730-2026-03-11-1741-1vss6kp","company_id":"6730","company":"常廣","market":"上櫃","industry":"生技醫療","date":"2026-03-11","time":"17:41:36","subject":"公告本公司董事會通過114年度員工酬勞及董事酬勞分配案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：常廣（6730），2026-03-11 17:41，「公告本公司董事會通過114年度員工酬勞及董事酬勞分配案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6847-2026-03-11-1734-157c1vm","company_id":"6847","company":"普瑞博","market":"興櫃","industry":"生技醫療","date":"2026-03-11","time":"17:34:46","subject":"公告本公司114年現金增資案延長特定人繳款期間暨補償方案及願負賠償責任之承諾書","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：普瑞博（6847），2026-03-11 17:34，「公告本公司114年現金增資案延長特定人繳款期間暨補償方案及願負賠償責任之承諾書」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4737-2026-03-11-1732-bwopfv","company_id":"4737","company":"華廣","market":"上市","industry":"生技醫療","date":"2026-03-11","time":"17:32:28","subject":"公告本公司董事會決議不分派股利","clause":"第14款","fact_date":"2026-03-11","cite_as":"公開資訊觀測站重大訊息：華廣（4737），2026-03-11 17:32，「公告本公司董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4737-2026-03-11-1731-iptd5t","company_id":"4737","company":"華廣","market":"上市","industry":"生技醫療","date":"2026-03-11","time":"17:31:16","subject":"公告本公司董事會召集民國115年股東常會相關事宜","clause":"第17款","fact_date":"2026-03-11","cite_as":"公開資訊觀測站重大訊息：華廣（4737），2026-03-11 17:31，「公告本公司董事會召集民國115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4127-2026-03-11-1730-1hz9x2g","company_id":"4127","company":"天良","market":"上櫃","industry":"生技醫療","date":"2026-03-11","time":"17:30:58","subject":"公告本公司董事會決議114年度股利分派","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：天良（4127），2026-03-11 17:30，「公告本公司董事會決議114年度股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3205-2026-03-11-1730-3sk96k","company_id":"3205","company":"佰研","market":"上櫃","industry":"生技醫療","date":"2026-03-11","time":"17:30:44","subject":"公告本公司董事會決議發行限制員工權利新股","clause":"第11款","fact_date":"2026-03-11","cite_as":"公開資訊觀測站重大訊息：佰研（3205），2026-03-11 17:30，「公告本公司董事會決議發行限制員工權利新股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6730-2026-03-11-1730-1hz9x2g","company_id":"6730","company":"常廣","market":"上櫃","industry":"生技醫療","date":"2026-03-11","time":"17:30:16","subject":"公告本公司董事會決議114年度股利分派","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：常廣（6730），2026-03-11 17:30，「公告本公司董事會決議114年度股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4737-2026-03-11-1730-s57fxa","company_id":"4737","company":"華廣","market":"上市","industry":"生技醫療","date":"2026-03-11","time":"17:30:12","subject":"公告本公司114年度合併財務報告業經董事會決議通過","clause":"第31款","fact_date":"2026-03-11","cite_as":"公開資訊觀測站重大訊息：華廣（4737），2026-03-11 17:30，「公告本公司114年度合併財務報告業經董事會決議通過」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6730-2026-03-11-1727-1dd9qx8","company_id":"6730","company":"常廣","market":"上櫃","industry":"生技醫療","date":"2026-03-11","time":"17:27:24","subject":"公告本公司董事會決議召開115年股東常會事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：常廣（6730），2026-03-11 17:27，「公告本公司董事會決議召開115年股東常會事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6677-2026-03-11-1725-84656m","company_id":"6677","company":"瑩碩生技","market":"興櫃","industry":"生技醫療","date":"2026-03-11","time":"17:25:04","subject":"公告本公司董事會通過內部稽核主管任命案","clause":"第11款","fact_date":"2026-03-11","cite_as":"公開資訊觀測站重大訊息：瑩碩生技（6677），2026-03-11 17:25，「公告本公司董事會通過內部稽核主管任命案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6808-2026-03-11-1724-11wjw0o","company_id":"6808","company":"三鼎生技","market":"興櫃","industry":"生技醫療","date":"2026-03-11","time":"17:24:24","subject":"公告本公司董事會決議股利分派","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：三鼎生技（6808），2026-03-11 17:24，「公告本公司董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6677-2026-03-11-1724-1hfjzzd","company_id":"6677","company":"瑩碩生技","market":"興櫃","industry":"生技醫療","date":"2026-03-11","time":"17:24:21","subject":"公告本公司董事會決議召開115年股東會常會相關事宜","clause":"第32款","fact_date":"2026-03-11","cite_as":"公開資訊觀測站重大訊息：瑩碩生技（6677），2026-03-11 17:24，「公告本公司董事會決議召開115年股東會常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3205-2026-03-11-1722-1ezkk7x","company_id":"3205","company":"佰研","market":"上櫃","industry":"生技醫療","date":"2026-03-11","time":"17:22:43","subject":"公告本公司董事會決議辦理私募現金增資發行普通股案","clause":"第11款","fact_date":"2026-03-11","cite_as":"公開資訊觀測站重大訊息：佰研（3205），2026-03-11 17:22，「公告本公司董事會決議辦理私募現金增資發行普通股案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6730-2026-03-11-1716-e6hr0k","company_id":"6730","company":"常廣","market":"上櫃","industry":"生技醫療","date":"2026-03-11","time":"17:16:43","subject":"公告本公司董事會通過114年度合併財務報表","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：常廣（6730），2026-03-11 17:16，「公告本公司董事會通過114年度合併財務報表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4127-2026-03-11-1714-1hdezzy","company_id":"4127","company":"天良","market":"上櫃","industry":"生技醫療","date":"2026-03-11","time":"17:14:47","subject":"公告本公司董事會決議不分配114年度員工酬勞及董事酬勞","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：天良（4127），2026-03-11 17:14，「公告本公司董事會決議不分配114年度員工酬勞及董事酬勞」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4127-2026-03-11-1713-12qdukc","company_id":"4127","company":"天良","market":"上櫃","industry":"生技醫療","date":"2026-03-11","time":"17:13:05","subject":"公告本公司114年度財務報告業經提報董事會通過","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：天良（4127），2026-03-11 17:13，「公告本公司114年度財務報告業經提報董事會通過」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3205-2026-03-11-1710-urdsl","company_id":"3205","company":"佰研","market":"上櫃","industry":"生技醫療","date":"2026-03-11","time":"17:10:45","subject":"公告本公司因配合會計師事務所內部輪調而更換會計師","clause":"第7款","fact_date":"2026-03-11","cite_as":"公開資訊觀測站重大訊息：佰研（3205），2026-03-11 17:10，「公告本公司因配合會計師事務所內部輪調而更換會計師」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6808-2026-03-11-1704-uqttu8","company_id":"6808","company":"三鼎生技","market":"興櫃","industry":"生技醫療","date":"2026-03-11","time":"17:04:47","subject":"公告本公司董事會決議通過一一四年度財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：三鼎生技（6808），2026-03-11 17:04，「公告本公司董事會決議通過一一四年度財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6808-2026-03-11-1702-1b1jesg","company_id":"6808","company":"三鼎生技","market":"興櫃","industry":"生技醫療","date":"2026-03-11","time":"17:02:51","subject":"公告本公司董事會決議召開一一五年股東常會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：三鼎生技（6808），2026-03-11 17:02，「公告本公司董事會決議召開一一五年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7814-2026-03-11-1658-bwopfv","company_id":"7814","company":"海昌生技","market":"上櫃","industry":"生技醫療","date":"2026-03-11","time":"16:58:46","subject":"公告本公司董事會決議不分派股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：海昌生技（7814），2026-03-11 16:58，「公告本公司董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6612-2026-03-11-1655-1xh3pay","company_id":"6612","company":"奈米醫材","market":"上櫃","industry":"生技醫療","date":"2026-03-11","time":"16:55:57","subject":"本公司115年股東會召開日期及召集事由","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：奈米醫材（6612），2026-03-11 16:55，「本公司115年股東會召開日期及召集事由」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6612-2026-03-11-1655-nob2a5","company_id":"6612","company":"奈米醫材","market":"上櫃","industry":"生技醫療","date":"2026-03-11","time":"16:55:34","subject":"公告本公司董事會決議盈餘轉增資發行新股","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：奈米醫材（6612），2026-03-11 16:55，「公告本公司董事會決議盈餘轉增資發行新股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7759-2026-03-11-1655-de87g1","company_id":"7759","company":"視航生醫","market":"興櫃","industry":"生技醫療","date":"2026-03-11","time":"16:55:02","subject":"公告本公司第一屆薪資報酬委員會委員異動","clause":"第6款","fact_date":"2026-03-11","cite_as":"公開資訊觀測站重大訊息：視航生醫（7759），2026-03-11 16:55，「公告本公司第一屆薪資報酬委員會委員異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7759-2026-03-11-1653-drgvb6","company_id":"7759","company":"視航生醫","market":"興櫃","industry":"生技醫療","date":"2026-03-11","time":"16:53:09","subject":"公告本公司累積虧損達實收資本額二分之一","clause":"第44款","fact_date":"2026-03-11","cite_as":"公開資訊觀測站重大訊息：視航生醫（7759），2026-03-11 16:53，「公告本公司累積虧損達實收資本額二分之一」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6612-2026-03-11-1653-13bqai2","company_id":"6612","company":"奈米醫材","market":"上櫃","industry":"生技醫療","date":"2026-03-11","time":"16:53:01","subject":"本公司董事會決議股利分派","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：奈米醫材（6612），2026-03-11 16:53，「本公司董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7762-2026-03-11-1652-11b1948","company_id":"7762","company":"吉晟生","market":"興櫃","industry":"生技醫療","date":"2026-03-11","time":"16:52:31","subject":"公告本公司董事會決議召開115年股東常會相關事宜","clause":"第32款","fact_date":"2026-03-11","cite_as":"公開資訊觀測站重大訊息：吉晟生（7762），2026-03-11 16:52，「公告本公司董事會決議召開115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6612-2026-03-11-1652-1r1w2m4","company_id":"6612","company":"奈米醫材","market":"上櫃","industry":"生技醫療","date":"2026-03-11","time":"16:52:18","subject":"本公司董事會通過114年度合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：奈米醫材（6612），2026-03-11 16:52，「本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6612-2026-03-11-1651-1v8d4ko","company_id":"6612","company":"奈米醫材","market":"上櫃","industry":"生技醫療","date":"2026-03-11","time":"16:51:46","subject":"代子公司碩創(上海)醫療器械有限公司公告-以辦理現金增資方式發行2026年員工認股計畫(員工認股權)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：奈米醫材（6612），2026-03-11 16:51，「代子公司碩創(上海)醫療器械有限公司公告-以辦理現金增資方式發行2026年員工認股計畫(員工認股權)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7759-2026-03-11-1651-15pqx47","company_id":"7759","company":"視航生醫","market":"興櫃","industry":"生技醫療","date":"2026-03-11","time":"16:51:30","subject":"公告本公司董事會決議通過114年度財務報告","clause":"第43款","fact_date":"2026-03-11","cite_as":"公開資訊觀測站重大訊息：視航生醫（7759），2026-03-11 16:51，「公告本公司董事會決議通過114年度財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6612-2026-03-11-1651-4ouq50","company_id":"6612","company":"奈米醫材","market":"上櫃","industry":"生技醫療","date":"2026-03-11","time":"16:51:18","subject":"本公司集團內組織架構重組","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：奈米醫材（6612），2026-03-11 16:51，「本公司集團內組織架構重組」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4111-2026-03-11-1646-92x690","company_id":"4111","company":"濟生","market":"上櫃","industry":"生技醫療","date":"2026-03-11","time":"16:46:45","subject":"董事會決議股利分派","clause":"第14款","fact_date":"2026-03-11","cite_as":"公開資訊觀測站重大訊息：濟生（4111），2026-03-11 16:46，「董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3205-2026-03-11-1646-hpkos1","company_id":"3205","company":"佰研","market":"上櫃","industry":"生技醫療","date":"2026-03-11","time":"16:46:06","subject":"公告增列本公司115年股東常會召集事由(議案更新)","clause":"第17款","fact_date":"2026-03-11","cite_as":"公開資訊觀測站重大訊息：佰研（3205），2026-03-11 16:46，「公告增列本公司115年股東常會召集事由(議案更新)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7759-2026-03-11-1646-11b1948","company_id":"7759","company":"視航生醫","market":"興櫃","industry":"生技醫療","date":"2026-03-11","time":"16:46:06","subject":"公告本公司董事會決議召開115年股東常會相關事宜","clause":"第32款","fact_date":"2026-03-11","cite_as":"公開資訊觀測站重大訊息：視航生醫（7759），2026-03-11 16:46，「公告本公司董事會決議召開115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7762-2026-03-11-1638-nob2a5","company_id":"7762","company":"吉晟生","market":"興櫃","industry":"生技醫療","date":"2026-03-11","time":"16:38:34","subject":"公告本公司董事會決議盈餘轉增資發行新股","clause":"第9款","fact_date":"2026-03-11","cite_as":"公開資訊觀測站重大訊息：吉晟生（7762），2026-03-11 16:38，「公告本公司董事會決議盈餘轉增資發行新股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7762-2026-03-11-1637-11wjw0o","company_id":"7762","company":"吉晟生","market":"興櫃","industry":"生技醫療","date":"2026-03-11","time":"16:37:42","subject":"公告本公司董事會決議股利分派","clause":"第31款","fact_date":"2026-03-11","cite_as":"公開資訊觀測站重大訊息：吉晟生（7762），2026-03-11 16:37，「公告本公司董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4111-2026-03-11-1637-1b89la1","company_id":"4111","company":"濟生","market":"上櫃","industry":"生技醫療","date":"2026-03-11","time":"16:37:31","subject":"公告本公司董事會通過114年度財務報告","clause":"第31款","fact_date":"2026-03-11","cite_as":"公開資訊觀測站重大訊息：濟生（4111），2026-03-11 16:37，「公告本公司董事會通過114年度財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7814-2026-03-11-1636-5j9yh6","company_id":"7814","company":"海昌生技","market":"上櫃","industry":"生技醫療","date":"2026-03-11","time":"16:36:26","subject":"公告本公司董事會通過114年度合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：海昌生技（7814），2026-03-11 16:36，「公告本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7762-2026-03-11-1626-1vss6kp","company_id":"7762","company":"吉晟生","market":"興櫃","industry":"生技醫療","date":"2026-03-11","time":"16:26:55","subject":"公告本公司董事會通過114年度員工酬勞及董事酬勞分配案","clause":"第44款","fact_date":"2026-03-11","cite_as":"公開資訊觀測站重大訊息：吉晟生（7762），2026-03-11 16:26，「公告本公司董事會通過114年度員工酬勞及董事酬勞分配案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7762-2026-03-11-1626-854nkg","company_id":"7762","company":"吉晟生","market":"興櫃","industry":"生技醫療","date":"2026-03-11","time":"16:26:10","subject":"公告本公司董事會決議不繼續辦理114年度股東常會通過之私募普通股案","clause":"第14款","fact_date":"2026-03-11","cite_as":"公開資訊觀測站重大訊息：吉晟生（7762），2026-03-11 16:26，「公告本公司董事會決議不繼續辦理114年度股東常會通過之私募普通股案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7876-2026-03-11-1618-1ltn00v","company_id":"7876","company":"鼎晉生技","market":"興櫃","industry":"生技醫療","date":"2026-03-11","time":"16:18:43","subject":"公告本公司受邀參加康和證券舉辦之法人說明會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：鼎晉生技（7876），2026-03-11 16:18，「公告本公司受邀參加康和證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7762-2026-03-11-1614-5j9yh6","company_id":"7762","company":"吉晟生","market":"興櫃","industry":"生技醫療","date":"2026-03-11","time":"16:14:35","subject":"公告本公司董事會通過114年度合併財務報告","clause":"第43款","fact_date":"2026-03-11","cite_as":"公開資訊觀測站重大訊息：吉晟生（7762），2026-03-11 16:14，「公告本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4111-2026-03-11-1609-17snutz","company_id":"4111","company":"濟生","market":"上櫃","industry":"生技醫療","date":"2026-03-11","time":"16:09:32","subject":"公告本公司董事會決議召開民國115年股東常會","clause":"第17款","fact_date":"2026-03-11","cite_as":"公開資訊觀測站重大訊息：濟生（4111），2026-03-11 16:09，「公告本公司董事會決議召開民國115年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3205-2026-03-11-1605-bwopfv","company_id":"3205","company":"佰研","market":"上櫃","industry":"生技醫療","date":"2026-03-11","time":"16:05:11","subject":"公告本公司董事會決議不分派股利","clause":"第14款","fact_date":"2026-03-11","cite_as":"公開資訊觀測站重大訊息：佰研（3205），2026-03-11 16:05，「公告本公司董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4142-2026-03-11-1603-1u7pahz","company_id":"4142","company":"國光生","market":"上市","industry":"生技醫療","date":"2026-03-11","time":"16:03:18","subject":"董事會決議不分派股利","clause":"第14款","fact_date":"2026-03-11","cite_as":"公開資訊觀測站重大訊息：國光生（4142），2026-03-11 16:03，「董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3716-2026-03-11-1603-yrlfft","company_id":"3716","company":"中化控股","market":"上市","industry":"生技醫療","date":"2026-03-11","time":"16:03:16","subject":"本公司召開115年股東常會相關事宜。(報告事項三更正)","clause":"第17款","fact_date":"2026-03-05","cite_as":"公開資訊觀測站重大訊息：中化控股（3716），2026-03-11 16:03，「本公司召開115年股東常會相關事宜。(報告事項三更正)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4142-2026-03-11-1602-5xjbf0","company_id":"4142","company":"國光生","market":"上市","industry":"生技醫療","date":"2026-03-11","time":"16:02:59","subject":"公告本公司董事會決議召開115年股東會相關事宜","clause":"第17款","fact_date":"2026-03-11","cite_as":"公開資訊觀測站重大訊息：國光生（4142），2026-03-11 16:02，「公告本公司董事會決議召開115年股東會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6875-2026-03-11-1602-1oaynm","company_id":"6875","company":"國邑*","market":"上櫃","industry":"生技醫療","date":"2026-03-11","time":"16:02:27","subject":"本公司受邀參加台新綜合證券舉辦之法人說明會","clause":"第12款","fact_date":"2026-03-17","cite_as":"公開資訊觀測站重大訊息：國邑*（6875），2026-03-11 16:02，「本公司受邀參加台新綜合證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4148-2026-03-11-1602-bux8ox","company_id":"4148","company":"全宇生技-KY","market":"上市","industry":"生技醫療","date":"2026-03-11","time":"16:02:25","subject":"更正114年12月份背書保證申報資訊","clause":"第51款","fact_date":"2026-03-11","cite_as":"公開資訊觀測站重大訊息：全宇生技-KY（4148），2026-03-11 16:02，「更正114年12月份背書保證申報資訊」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6492-2026-03-11-1559-wjkoq4","company_id":"6492","company":"生華科","market":"上櫃","industry":"生技醫療","date":"2026-03-11","time":"15:59:01","subject":"公告本公司內部稽核主管異動案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：生華科（6492），2026-03-11 15:59，「公告本公司內部稽核主管異動案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7759-2026-03-11-1558-bwopfv","company_id":"7759","company":"視航生醫","market":"興櫃","industry":"生技醫療","date":"2026-03-11","time":"15:58:21","subject":"公告本公司董事會決議不分派股利","clause":"第31款","fact_date":"2026-03-11","cite_as":"公開資訊觀測站重大訊息：視航生醫（7759），2026-03-11 15:58，「公告本公司董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7799-2026-03-11-1557-tqzpae","company_id":"7799","company":"禾榮科","market":"上市","industry":"生技醫療","date":"2026-03-11","time":"15:57:52","subject":"本公司有價證券於集中交易市場達公布注意交易資訊標準，故公布相關財務業務等重大訊息，以利投資人區別瞭解","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：禾榮科（7799），2026-03-11 15:57，「本公司有價證券於集中交易市場達公布注意交易資訊標準，故公布相關財務業務等重大訊息，以利投資人區別瞭解」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7799-2026-03-11-1557-ps7z81","company_id":"7799","company":"禾榮科","market":"上市","industry":"生技醫療","date":"2026-03-11","time":"15:57:40","subject":"公告本公司獨立董事辭任功能性委員會職務","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：禾榮科（7799），2026-03-11 15:57，「公告本公司獨立董事辭任功能性委員會職務」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7799-2026-03-11-1557-qrsqda","company_id":"7799","company":"禾榮科","market":"上市","industry":"生技醫療","date":"2026-03-11","time":"15:57:32","subject":"公告本公司獨立董事辭任","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：禾榮科（7799），2026-03-11 15:57，「公告本公司獨立董事辭任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3205-2026-03-11-1545-gfep1d","company_id":"3205","company":"佰研","market":"上櫃","industry":"生技醫療","date":"2026-03-11","time":"15:45:37","subject":"公告本公司董事會通過114年第4季合併財務報告","clause":"第31款","fact_date":"2026-03-11","cite_as":"公開資訊觀測站重大訊息：佰研（3205），2026-03-11 15:45，「公告本公司董事會通過114年第4季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6872-2026-03-11-1541-18q4sog","company_id":"6872","company":"浩宇生醫","market":"上櫃","industry":"生技醫療","date":"2026-03-11","time":"15:41:17","subject":"公告本公司董事會決議虧損撥補暨不發放股利","clause":"第14款","fact_date":"2026-03-11","cite_as":"公開資訊觀測站重大訊息：浩宇生醫（6872），2026-03-11 15:41，「公告本公司董事會決議虧損撥補暨不發放股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6492-2026-03-11-1538-1rpvd","company_id":"6492","company":"生華科","market":"上櫃","industry":"生技醫療","date":"2026-03-11","time":"15:38:49","subject":"公告本公司董事會決議辦理國內現金增資發行普通股","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：生華科（6492），2026-03-11 15:38，「公告本公司董事會決議辦理國內現金增資發行普通股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6872-2026-03-11-1533-drgvb6","company_id":"6872","company":"浩宇生醫","market":"上櫃","industry":"生技醫療","date":"2026-03-11","time":"15:33:39","subject":"公告本公司累積虧損達實收資本額二分之一","clause":"第53款","fact_date":"2026-03-11","cite_as":"公開資訊觀測站重大訊息：浩宇生醫（6872），2026-03-11 15:33，「公告本公司累積虧損達實收資本額二分之一」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6872-2026-03-11-1530-5j9yh6","company_id":"6872","company":"浩宇生醫","market":"上櫃","industry":"生技醫療","date":"2026-03-11","time":"15:30:35","subject":"公告本公司董事會通過114年度合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩宇生醫（6872），2026-03-11 15:30，「公告本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6872-2026-03-11-1520-1howjn","company_id":"6872","company":"浩宇生醫","market":"上櫃","industry":"生技醫療","date":"2026-03-11","time":"15:20:26","subject":"公告本公司董事會決議召開115年股東常會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩宇生醫（6872），2026-03-11 15:20，「公告本公司董事會決議召開115年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6492-2026-03-11-1520-bwopfv","company_id":"6492","company":"生華科","market":"上櫃","industry":"生技醫療","date":"2026-03-11","time":"15:20:22","subject":"公告本公司董事會決議不分派股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：生華科（6492），2026-03-11 15:20，「公告本公司董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6931-2026-03-11-1510-hiye2a","company_id":"6931","company":"青松健康","market":"上市","industry":"生技醫療","date":"2026-03-11","time":"15:10:28","subject":"代子公司青松長照社團法人公告董事會通過盈餘分派案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：青松健康（6931），2026-03-11 15:10，「代子公司青松長照社團法人公告董事會通過盈餘分派案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6931-2026-03-11-1510-1ap4bzl","company_id":"6931","company":"青松健康","market":"上市","industry":"生技醫療","date":"2026-03-11","time":"15:10:02","subject":"代子公司青松長照社團法人董事會通過114年度財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：青松健康（6931），2026-03-11 15:10，「代子公司青松長照社團法人董事會通過114年度財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6598-2026-03-11-1504-11wjw0o","company_id":"6598","company":"ABC-KY","market":"上市","industry":"生技醫療","date":"2026-03-11","time":"15:04:08","subject":"公告本公司董事會決議股利分派","clause":"第14款","fact_date":"2026-03-11","cite_as":"公開資訊觀測站重大訊息：ABC-KY（6598），2026-03-11 15:04，「公告本公司董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6598-2026-03-11-1503-11b1948","company_id":"6598","company":"ABC-KY","market":"上市","industry":"生技醫療","date":"2026-03-11","time":"15:03:32","subject":"公告本公司董事會決議召開115年股東常會相關事宜","clause":"第17款","fact_date":"2026-03-11","cite_as":"公開資訊觀測站重大訊息：ABC-KY（6598），2026-03-11 15:03，「公告本公司董事會決議召開115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6598-2026-03-11-1502-5j9yh6","company_id":"6598","company":"ABC-KY","market":"上市","industry":"生技醫療","date":"2026-03-11","time":"15:02:31","subject":"公告本公司董事會通過114年度合併財務報告","clause":"第31款","fact_date":"2026-03-11","cite_as":"公開資訊觀測站重大訊息：ABC-KY（6598），2026-03-11 15:02，「公告本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4142-2026-03-11-1445-1qj44hg","company_id":"4142","company":"國光生","market":"上市","industry":"生技醫療","date":"2026-03-11","time":"14:45:30","subject":"公告本公司財務主管異動","clause":"第8款","fact_date":"2026-03-11","cite_as":"公開資訊觀測站重大訊息：國光生（4142），2026-03-11 14:45，「公告本公司財務主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4142-2026-03-11-1443-5j9yh6","company_id":"4142","company":"國光生","market":"上市","industry":"生技醫療","date":"2026-03-11","time":"14:43:05","subject":"公告本公司董事會通過114年度合併財務報告","clause":"第31款","fact_date":"2026-03-11","cite_as":"公開資訊觀測站重大訊息：國光生（4142），2026-03-11 14:43，「公告本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6872-2026-03-11-1435-1o98txl","company_id":"6872","company":"浩宇生醫","market":"上櫃","industry":"生技醫療","date":"2026-03-11","time":"14:35:17","subject":"公告本公司董事會決議辦理現金增資私募普通股案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩宇生醫（6872），2026-03-11 14:35，「公告本公司董事會決議辦理現金增資私募普通股案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6492-2026-03-11-1427-1yl6b9r","company_id":"6492","company":"生華科","market":"上櫃","industry":"生技醫療","date":"2026-03-11","time":"14:27:17","subject":"公告本公司董事會決議召開股東常會事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：生華科（6492），2026-03-11 14:27，「公告本公司董事會決議召開股東常會事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6838-2026-03-11-1407-1cjtkf0","company_id":"6838","company":"台新藥","market":"上市","industry":"生技醫療","date":"2026-03-11","time":"14:07:08","subject":"更正本公司董事會通過召集民國一一五年度股東常會相關事宜(修正召集事由順序)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台新藥（6838），2026-03-11 14:07，「更正本公司董事會通過召集民國一一五年度股東常會相關事宜(修正召集事由順序)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6492-2026-03-11-1354-5j9yh6","company_id":"6492","company":"生華科","market":"上櫃","industry":"生技醫療","date":"2026-03-11","time":"13:54:16","subject":"公告本公司董事會通過114年度合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：生華科（6492），2026-03-11 13:54，「公告本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6615-2026-03-11-1223-11wjw0o","company_id":"6615","company":"慧智","market":"上櫃","industry":"生技醫療","date":"2026-03-11","time":"12:23:19","subject":"公告本公司董事會決議股利分派","clause":"第14款","fact_date":"2026-03-11","cite_as":"公開資訊觀測站重大訊息：慧智（6615），2026-03-11 12:23，「公告本公司董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6615-2026-03-11-1221-kosdjo","company_id":"6615","company":"慧智","market":"上櫃","industry":"生技醫療","date":"2026-03-11","time":"12:21:23","subject":"本公司董事會決議召開115年股東常會相關事宜公告","clause":"第17款","fact_date":"2026-03-11","cite_as":"公開資訊觀測站重大訊息：慧智（6615），2026-03-11 12:21，「本公司董事會決議召開115年股東常會相關事宜公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6615-2026-03-11-1217-5j9yh6","company_id":"6615","company":"慧智","market":"上櫃","industry":"生技醫療","date":"2026-03-11","time":"12:17:10","subject":"公告本公司董事會通過114年度合併財務報告","clause":"第31款","fact_date":"2026-03-11","cite_as":"公開資訊觀測站重大訊息：慧智（6615），2026-03-11 12:17，「公告本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6661-2026-03-11-1020-13sdm4q","company_id":"6661","company":"威健生技","market":"上櫃","industry":"生技醫療","date":"2026-03-11","time":"10:20:52","subject":"更正本公司董事會決議召開股東常會-最後過戶日以郵寄辦理之日期","clause":"第17款","fact_date":"2026-03-10","cite_as":"公開資訊觀測站重大訊息：威健生技（6661），2026-03-11 10:20，「更正本公司董事會決議召開股東常會-最後過戶日以郵寄辦理之日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}